Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The L protein of respiratory syncytial virus (RSV) is a large, multifunctional enzyme that serves as the viral RNA-dependent RNA polymerase (RdRp). It is essential for RSV genome replication and transcription, catalyzing several enzymatic activities required for the synthesis and processing of viral RNAs. The functional polymerase complex minimally requires two proteins: L and P (phosphoprotein). The multiple catalytic activities housed within one polypeptide make L an attractive target for antiviral intervention.
Inhibition of RNA-dependent RNA polymerase activity, inhibition of mRNA capping, inhibition of mRNA methylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L Protein (RNA-dependent RNA Polymerase) of Respiratory Syncytial Virus (L protein).